Without cyanobacteria, natural history wouldn’t be much to talk about. Now these billions of years old microbes help the development of bioenergy and medicines.
New Director for FIMM
Olli Kallioniemi will head the Institute for Molecular Medicine Finland.
Academy Professor (MD, PhD) Olli Kallioniemi has been appointed as the Director of the Institute for Molecular Medicine Finland (FIMM) for a five-year period starting December 1, 2007. Since 2002 Kallioniemi has been Research Director of the Medical Biotechnology Centre of VTT Technical Research Centre of Finland in Turku.
The Institute for Molecular Medicine Finland is a joint research institute of the University of Helsinki, the Hospital District of Helsinki and Uusimaa (HUS) and the National Public Health Insititute (KTL). The aim of FIMM is to merge resources and research in the field of molecular medicine, genetics and epidemiology in Finland, and to develop into a high-profile international research institute.
Together with its sister institutes established in Umeå University and University of Oslo FIMM forms a partnership network with the European Molecular Biology Laboratory EMBL. The agreement for establishing the Nordic EMBL Partnership for Molecular Medicine was signed on October 3, 2007 in Heidelberg.
The main laboratory of FIMM will be located on the Meilahti medical campus in the Biomedicum Helsinki 2 building which will be completed in January 2008. Finnish as well as international researchers will conduct their research in the laboratory. The recruitment of the first international group leaders is underway.
Text: Päivi Lehtinen
Photo: Otto Väätäinen
3.10.2007
www.helsinki.fi/digitalcommunications
Receive news via RSS feed >>News of the month >>
News archive >>
World Design Capital Helsinki 2012
International Conferences in Helsinki
Seminars at UH
All Seminars >>Exhibitions:
- Botanic Garden
- Finnish Museum of Natural History
- Helsinki University Library
- Helsinki University Museum
Advertisements:
- Rooms and flats (mostly in Finnish)